Clinical Trial Search

Primary: Number of Participants With One or More Adverse Events Related to Study Drug — 6 Participants

Primary: Change of Heart Rate After Delayed Umbilical Clamping — 164; 157; 163; 155 bpm

Primary: Mean Change From Baseline in V-Scale Composite Score (Sum of 9 Sub-Domains) of Vineland Adaptive Behavior Scales Second Edition-Parent Caregiver Rating Form…

Primary: Number of Participants With One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration — 0; 0; 0; 0 Participants

Primary: Proportion of Subjects With at Least a 3 Line (15 Letter) Improvement in Near Visual Acuity in the Study Eye — 47.22; 47.22; 2.38 percentage of participants — p=0.0009

Primary: Number of Participants With Treatment Emergent Adverse Events and Serious Adverse Events — 8; 9; 0; 0 Participants

Primary: Overall Clinical Success in Number and Size of Lesions as Measured by Photographic or Other Imaging Modality Depending on the Organ System Affected or Change in Affected…

Primary: Enrollment Rate — 0.36 Percent probability of participants

Primary: Objective Response Rate (ORR) — 25.00; 37.50; 75.00; 62.50 percentage of patients

Primary: Peak Itch Intensity Between the Vehicle and Active Treatments During Non-histaminergic Itch Induction — 4.5; 3.94; 5.32; 5.79 Intensity score

Primary: Perceived Stress Scale (PSS) — 19.63; 18.80; 17.29; 18.54 score on a scale

Primary: Pain VAS Score — 75; 60; 55 score on a scale

Primary: Change in the Relative Abundance of Lactobacillus — 0.143 proportion of total microbes

Primary: Number of Participants With Dose-Limiting Toxicities as Assessed by Reported Data — 0; 1 Participants

Primary: Decisional Conflict Scale — 6.9; 11 score on a scale — p=0.05